These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24798303)

  • 21. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-361-5p Inhibits Cancer Cell Growth by Targeting CXCR6 in Hepatocellular Carcinoma.
    Sun JJ; Chen GY; Xie ZT
    Cell Physiol Biochem; 2016; 38(2):777-85. PubMed ID: 26872014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 24. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
    Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
    J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a.
    Song G; Tian L; Cheng Y; Liu J; Wang K; Li S; Li T
    J Cell Biochem; 2019 Oct; 120(10):18152-18161. PubMed ID: 31190353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
    Grossi I; Arici B; Portolani N; De Petro G; Salvi A
    Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 28. miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1.
    Mahati S; Xiao L; Yang Y; Mao R; Bao Y
    Biochem Biophys Res Commun; 2017 May; 486(3):732-737. PubMed ID: 28342862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.
    Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q
    Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.
    Cheng D; Deng J; Zhang B; He X; Meng Z; Li G; Ye H; Zheng S; Wei L; Deng X; Chen R; Zhou J
    EBioMedicine; 2018 Oct; 36():159-170. PubMed ID: 30195653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
    Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
    Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137.
    Gao Y; Gu J; Wang Y; Fu D; Zhang W; Zheng G; Wang X
    Pathol Res Pract; 2020 Jun; 216(6):152981. PubMed ID: 32527447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.
    Zhang Y; Zhang D; Jiang J; Dong L
    Oncol Rep; 2017 Jan; 37(1):323-332. PubMed ID: 27878280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.
    Zhang C; Li H; Jiang W; Zhang X; Li G
    Oncotarget; 2016 Dec; 7(50):83755-83766. PubMed ID: 27835879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
    Fouda MS; Omran MM; Tarek G; Hady A Abdel Wahab A
    Arab J Gastroenterol; 2021 Mar; 22(1):28-33. PubMed ID: 33268243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
    Qu W; Wen X; Su K; Gou W
    J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
    Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
    Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.